Approval · Notice of Compliance 1381 · 2000
ONCASPAR: Notice of Compliance 1381
Issued October 24, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1381
- Date
- October 24, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONCASPAR | 02236849 | Cancelled Post Market |
Medicinal ingredients
- PEGASPARGASE 750 UNIT per ML